Ardelyx, a biopharmaceutical company, announced it will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 17, 2026. The event will feature discussions on Ardelyx's innovative medicines, including its commercial products IBSRELA and XPHOZAH, and its ongoing Phase 3 clinical trials. Investors and interested parties can access a live webcast and replay via Ardelyx's website. This participation highlights Ardelyx's efforts to engage with the healthcare investment community and update on its pipeline progress.
Ardelyx's participation at the Jefferies Global Healthcare Conference in London coincides with a broadly positive day for health-sector stocks on Pluang. For readers following the health sector, here is Pluang's market snapshot as of Nov 10, 2026 18:42 WIB: out of 150 priced US health stocks, 85 rose and 56 fell. Notable movers include ABEO at USD 2.60 with a 1-day change of +2.36% and a typical hold time of 24 days, DFTX at USD 36.18 with a 1-day change of +2.23% and 100% buy order activity, and TVTX at USD 50.50 with a 1-day change of -2.19%.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
